March 24: rfxcel CEO Glenn Abood explains how real-time environmental monitoring can combat supply chain shortcomings, providing companies with a level of data integrity, traceability, transparency and security that is virtually beyond reproach.
Category: Pharma Publications
How to optimize the pharma supply chain to aid smooth delivery of COVID-19 vaccines
October 2020: rfxcel CEO Glenn Abood talks with Biopharma-Reporter.
What Pharma Dispensers Need to Do to Comply with the U.S. Drug Supply Chain Security Act
October 2020: rfxcel’s DSCSA Strategic Advisor Brian Files writes in Supply & Demand Chain Executive.
An Overview of Russia’s Pharma Serialization Regulations and its National Track and Trace Digital System, Chestny ZNAK
March 2020: rfxcel’s General Director in Moscow Victoria Kozlova writes in World Pharma Today.
Top Four Questions About Russia’s Serialization Laws, Answered
February 2020: rfxcel’s General Director in Moscow Victoria Kozlova writes in Supply Chain Brain.
The Elegant Fundamentals
January 2020: rfxcel VP of Quality Management & Validation Amit Sewak writes in European Biopharmaceutical Review.
Securing the Pharma Supply Chain: A Look Back at How We Got Here and Where We’re Going
December 2019: rfxcel’s CEO Glenn Abood writes in International Pharmaceutical Industry.
Future-proofing product alerts and recalls
December 2019: rfxcel VP of Marketing and Strategic Initiatives Herb Wong writes in Healthcare Purchasing News.
Asian pharma companies prepare for Russian regulations
October 2019: rfxcel’s General Director in Moscow Victoria Kozlova writes in BioSpectrum.
Steps to Compliance: How Best to Prepare for Russia’s 2020 Pharma Regulations
May 2019: rfxcel’s General Director in Moscow writes in World Pharma Today.